Characterization of priMary And sEcondary STress Related takOtsubo

Recruiting N/A Interventional Study
Takotsubo Cardiomyopathy Sepsis-induced Cardiomyopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
60 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Takotsubo syndrome (TTS) is an acute and reversible form of myocardial injury often preceded by a physical or emotional trigger. Although TTS was generally considered a benign disease for its reversible nature, it is now clear that hemodynamic and electrical instability during the acute phase exposes patients to frequent serious adverse in-hospital complications. However, the pathophysiology of TT…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For patients with TTS: * Informed consent signed by the patient or parent/guardian/legal representative. * TTS diagnosed based on modified Mayo Clinic Diagnostic Criteria as: (i) transient wall motion abnormality in the left ventricle beyond a single epicardial coronary artery …
Contacts

Rocco A Montone, MD, PhD

+39-0630154187

roccoantonio.montone@policlinicogemelli.it

CONTACT